Edinburgh, UK, 16th May 2019 / Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partners
On the first day, CSO Michael Roberts presented to a packed room as part of the Tools & Technologies Forum.
David Venables presented to a full room of investors at the ARM Cell & Gene Therapy Investor Day in New York.
Edinburgh, UK, 5th December 2018 / Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, develope
Edinburgh, UK, 16th November 2018 / Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the